End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.42 EGP | -0.82% | -1.63% | -22.93% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 36.64B 774M | Sales 2025 * | 46.76B 987M | Capitalization | 2.44B 51.52M |
---|---|---|---|---|---|
Net income 2024 * | 417M 8.81M | Net income 2025 * | 448M 9.46M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.65B 77.06M | Net Debt 2025 * | 3.44B 72.68M | EV / Sales 2025 * | 0.13 x |
P/E ratio 2024 * |
8.07
x | P/E ratio 2025 * |
5.85
x | Employees | 5,500 |
Yield 2024 * |
2.42% | Yield 2025 * |
2.73% | Free-Float | 61.4% |
1 day | -0.82% | ||
1 week | -1.63% | ||
Current month | +2.11% | ||
1 month | -8.33% | ||
3 months | -29.45% | ||
6 months | +1.26% | ||
Current year | -22.93% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 2.42 | -0.82% | 4,970,738 |
24-05-08 | 2.44 | -0.81% | 11,752,150 |
24-05-07 | 2.46 | 0.00% | 8,477,370 |
24-05-02 | 2.46 | +1.23% | 9,682,173 |
End-of-day quote Egyptian Exchange, May 08, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.93% | 51.47M | |
-34.16% | 14.83B | |
-24.55% | 12.04B | |
-25.24% | 6.52B | |
+14.96% | 6.44B | |
-8.01% | 6.15B | |
-2.34% | 4.64B | |
+60.00% | 4.62B | |
-8.10% | 3.93B | |
-11.16% | 3.49B |
- Stock Market
- Equities
- ISPH Stock